Eli Lilly Revenue Jumps on Sales of Weight-Loss Drug
Wall Street Journal
The drug maker raised its full-year revenue and earnings guidance, driven by Mounjaro and Zepbound sales. Shares rose 7% premarket.
https://www.wsj.com/articles/eli-lilly-revenue-jumps-on-sales-of-weight-loss-drug-ae3684b8